Volume 22, Number 1—January 2016
Dispatch
Rapid Emergence and Clonal Dissemination of CTX-M-15–Producing Salmonella enterica Serotype Virchow, South Korea
Jin Seok Kim1, Young-Sun Yun1, Soo Jin Kim, Se-Eun Jeon, Deog-yong Lee, Gyung Tae Chung, Cheon-Kwon Yoo, Junyoung Kim
, and PulseNet Korea Working Group
, and PulseNet Korea Working Group
Table
Antimicrobial resistance profiles of Salmonella enterica serotype Virchow isolates in South Korea, 2005–2014*
| Isolate no. | Antimicrobial drug | No. resistant isolates |
|---|---|---|
| 1 | – | 14 |
| 2 | NAL | 18 |
| 3 | TCY | 2 |
| 4 | NAL, SXT | 2 |
| 5 | TCY, NAL | 2 |
| 6 | AMP, CEF, CTX, NAL | 5 |
| 7 | AMP, CEF, CTX, NAL, TCY | 7 |
| 8 | AMP, CEF, CTX, GEN, NAL | 1 |
| 9 | AMP, CEF, CTX, GEN, NAL, TCY | 15 |
| 10 | AMC, AMP, CEF, CTX, FOX, SAM, NAL | 1 |
| 11 |
AMC, AMP, CEF, CTX, FOX, SAM, NAL, TCY |
1 |
| Total | 68 |
*AMC, amoxicillin/clavulanic acid; AMP, ampicillin; CEF, cephalothin; CTX, cefotaxime; FOX, cefoxitin; GEN, gentamicin; NAL, nalidixic acid; SAM, ampicillin/sulbactam; SXT, trimethoprim/sulfamethoxazole; TCY, tetracycline; –, pansusceptible.
1These co–first authors contributed equally to this article.
2Members of the PulseNet Korea Working Group are listed at the end of the article.
Page created: December 18, 2015
Page updated: December 18, 2015
Page reviewed: December 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.